Parents, please be advised that some EpiPens can fail to activate in an emergency. Here’s what you need to know about this scary recall.

By Melissa Willets
April 03, 2017

Mylan, the maker of EpiPen, is in the news again, and not because of a crazy new price hike. This time, the issue is even more concerning: Some EpiPens may fail to activate and are being recalled.

In March, the company recalled 81,000 EpiPens in Europe, Australia, New Zealand, and Japan, according to Forbes. But now, the recall has spread to 13 lots of the EpiPen and EpiPen Jr. Auto-Injector after two reports that the life-saving pen did not activate when needed.

EpiPen 2 pack recall

Pretty scary stuff, considering that a dose of epinephrine administered immediately after an allergic reaction takes place can mean the difference between life and death. Plus, it’s estimated that 1 in 13 kids has a food allergy in the U.S.

It’s important to note that this recall affects both EpiPens parents keep on hand at home in case of an allergic reaction, but also those they supply to schools and daycares. In fact, my child’s school sent out a newsletter this morning alerting parents about the recall.

Visit Mylan’s site to see full details about the recall, including exactly which products are affected, their lot numbers, and expiration dates. Reportedly the number of pens included in the recall is small, and the generic form of the medication is safe.

According to a statement by the company, “Mylan is committed to replacing recalled devices at no cost and Mylan would like to reassure patients that there will be no additional replacement-related financial burden to them as a result of this recall.”

Melissa Willets is a writer/blogger and soon-to-be mom of 4. Find her on Facebook where she chronicles her life momming under the influence. Of yoga.